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Abstract 
Organelles take various forms of shapes and sizes. Alteration to its structure allows organelles to 
either carry out unique tasks or to adapt to the ever-changing cellular environment. For example, 
the reticular nature of the peripheral endoplasmic reticulum is important for the passage of 
macromolecules from the cytosol to the plasma membrane whereas fragmented forms of 
mitochondria ensure proper segregation to the daughter cells during mitosis [1,2,3]. Another 
example will be mitochondria forming donut shaped structures after hypoxia-reoxygenation [4]. 
Thus, the morphology of organelles plays an active role in countless critical cellular processes, 
and therefore, it is not surprising for researchers to study the relation between morphology and 
different disease states.  
To date, it is clear what consequences each type of morphology is associated with; however, it is 
yet to be determined whether the morphology itself can bring about certain ramifications. This 
results from the limitations in tools to dissociate the role of morphology from the complex 
signaling network. As a result, a natural question will be whether it is possible to develop a tool 
that can directly manipulate organelle morphology so that it is possible to inquire into the effects 
of perturbed organelle morphology in a stepwise manner. 
 iii 
This paper will focus particularly on mitochondrial morphology and introduce the biochemistry of 
mitochondrial dynamics, diseases associated with impaired mitochondrial morphology, and 
current tools to unravel mitochondrial physiology.  
Lastly, the paper will survey a novel tool that could potentially be used to dissect the role of 
mitochondrial morphology through direct manipulation of its morphology which will be the first 
tool to exploit actin-based forces to achieve this. 
Advisor: Dr. Takanari Inoue 
Readers: Dr. Takanari Inoue; Dr. Rebecca Schulman; Dr. Kevin Yarema 
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Mitochondrial Dynamics and Current Tools  
1. Mitochondria Dynamics 
Mitochondria morphology is dynamically shaped through the balance of fusion and fission.  Fusion 
is the process where two organelles come together to become a single identity. It is an intricate 
and delicate procedure where multiple proteins are involved to rupture, deform, and merge the 
lipid bilayers. Fusion starts off by joining the outer membranes together under the coordination of 
dynamin- like GTPases such as mitofusins 1 and 2 (Mfn1 and Mfn2) [3,4,5,6,7]. Mfns contain a 
conserved GTPase domain and coiled-coil structure at its carboxyl-tail, and they mediate outer-
membrane fusion through homo- and heterotypic interactions at the expense of GTP [5,7]. This 
causes a conformational change allowing to membrane structure to fuse together (Fig 1.1). Inner 
membrane fusion occurs in a similar fashion but instead requires a GTPase called Opa1 (Fig 1.1) 
[7,8]. The coordination between inner and outer membrane fusion is yet to be understood, but 
current belief is that the two events work together through an adaptor protein which somehow links 
the two inner and outer membrane fusion proteins and allowing information exchange.   
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Figure 1.1: Mechanism of Mitochondrial Fusion. A schematic 
of mitochondrial outer (Mfn2) and inner membrane fusion 
proteins (Opa1). (Adapted from A. B. Knott and G. Perkins, 
Nature Reviews Neuroscience 2008) 
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Figure 1.2: Mechanism of Mitochondrial Fission. An illustration of mitochondrial fission 
protein, Drp1, involved in mitochondrial fragmentation (Adapted from A. B. Knott and G. 
Perkins, Nature Reviews Neuroscience 2008) 
 Mitochondrial fission involves a dynamin-related protein, Drp1 [9]. One unique property of Drp1 
is that majority of Drp1 remains cytosolic but can self-assemble on the mitochondrial membrane 
and subsequently induce GTP hydrolysis to generate a constriction force (Fig 1.2) [7,9,10]. Recent 
reports postulate that actin filaments may accelerate Drp1 oligomerization at the membrane by 
promoting its interaction with receptors such as mitochondrial fission factor (MFF) [10,11]. On 
the mitochondrial membrane, Drp1 forms a spiral-helix, and upon GTP hydrolysis, the helices 
rotate relative to each other promoting constriction [7,9,10,11].  
2.  Disruption of Mitochondrial Morphology and 
Diseases  
 So why is mitochondrial dynamics important? It has been reported that mitochondrial fusion is 
imperative for maximizing ATP production and facilitating content exchange [5,6,7,12]. This 
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serves as a protective mechanism for individual mitochondria that would otherwise be susceptible 
to damage. On the other hand, mitochondrial fission is vital for segregating damaged mitochond r ia 
from healthy pool of mitochondria for elimination [13], and has been typically linked with 
apoptosis [14,15]. Mitochondrial fission is also important in cell division to equally distribute 
mitochondria to daughter cells [16]. Thus, mitochondrial dynamics takes a large part in 
maintaining cellular integrity, energy production, calcium regulation, and cell division. Therefore, 
it is unsurprising that defects in mitochondrial dynamics is associated with many devastating 
diseases such as neuronal and myocardial diseases.  
Due to the large energy demand, numerous neuronal processes rely on mitochondrial dynamics 
and neurodegenerative diseases arise as a consequence of deficiency in mitochondrial fusion and 
fission proteins. In particular, mutations in the Mfn2 gene leads to diseases such as Charcot-Marie-
Tooth disease (CMT), a peripheral neuropathy that is characterized by muscle weakness and 
axonal degradation of sensory and motor neurons., hereditary motor and sensory neuropathy which 
results in optic atrophy and visual impairments [17,18]. Mutations in Opa1 cause a more common 
optic atrophy, autosomal dominant optic atrophy (ADOA) [6,17,18].  
Heart failures are another common disorder resulting from impairment in mitochondr ia l 
morphology. Recent studies by Thomas Langer have shown that the dysregulation of 
mitochondrial morphology leads to changes in metabolic status, a shift from fatty acid oxidation 
to glucose utilization, in cardiomyocytes and this precedes heart failure [19]. It has been shown 
that the L-Opa1 mediated mitochondrial fusion preserves cardiac function whereas proteolytic 
processing of L-Opa1 to S-Opa1 by a mitochondrial protease, OMA1, triggers dilated 
cardiomyopathy and heart failure [19].  
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3. Tools to Understand Mitochondrial Dynamics and 
Limitations 
As much as mitochondrial dynamics is important, to date, various methods and tools to study 
mitochondrial function have been developed. These tools range from dyes and drugs to genetica lly 
encoded proteins that can either measure various parameters of the mitochondria such as 
membrane potential, ATP levels, calcium levels, etc. or tools such as CCCP and knock out models 
to perturb the mitochondrial integrity to understand the effects of morphological and functiona l 
defects [20]. Although many of these tools have broaden our understanding of the field of 
mitochondrial dynamics, they are still far from being perfect.  
Carbonyl cyanide m-chlorophenyl hydrazine (CCCP) is a chemical drug that has been widely used 
to understand mitochondrial functionality rather than morphological studies. It decreases 
mitochondrial membrane potential by binding to protons in the intermembrane space and 
transferring into the matrix [21]. The uncoupling of proton gradient induces a pathway that leads 
to activation of various processes that causes mitochondrial fragmentation and degradation. 
Therefore, because of its acute effects on the membrane potential, it is typically used in studying 
mitophagy and consequences of impaired mitochondria [22,23,24].   
Several small molecules to study mitochondrial dynamics has been reported. Dynasore is a small 
molecule that inhibits the GTPase activity of dynamin. It noncompetitively binds to the GTPase 
domain of all dynamins in both assembled and unassembled states [25,26]. However, one issue is 
that it is unspecific and inhibits all dynamins (dynamin1, dynamin2, and Drp1) [25,26]. GTPγs, a 
non-hydrolyzable GTP, is another method to inhibit Drp1, but once again antagonizes all GTPases 
[27]. To address the limitations of current inhibitors, a novel inhibitor, Mdivi-1, has been 
developed. It is postulated that Mdivi-1 selectively binds to an allosteric site of mitochondr ia l 
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division Drp1 that does not act through the GTPase domain. Upon Mdivi-1 binding, it is speculated 
that Drp1 is locked into an unassembled form which cannot assemble into Drp1 filaments/spira ls; 
however, there is no convincing evidence such is the case [27,28,29]. In addition, recent report 
suggests that Mdivi-1 is more of a mitochondrial complex 1 inhibitor rather than Drp1 inhib itor 
[30]. They’ve shown that there are discrepancies in phenotypes between Drp1 KO cells and Mdivi-
1 cells and attributed the effects of Mdivi-1 to Drp1-independent mechanisms such as regulat ion 
of mitochondrial fusion proteins [31]. Despite the fact these drugs circumvent the need for 
generating mutant or knockout models and provide an opportunity to take discrete steps to 
understand mitochondrial dynamics rapidly, there is still an imperfect understanding of the 
mechanism and the extent of these approaches [30].  
In the case of knock out models, they have their own set of limitations when used to study 
mitochondrial morphology. One example is knocking out fusion/fission proteins or overexpressing 
its counterpart leads to different functional changes in the mitochondria. For example, deletion of 
Mfn2 in skeletal muscle causes mitochondrial fragmentation which ruins the metabolic signaling 
of these tissues. On the contrary, overexpression of Drp1 does not cause mitochondr ia l 
fragmentation but results in increased mitochondrial length. In case of the liver, deletion of Drp1 
induces mitochondrial fragmentation [6]. Thus, deletion of the same protein can result in different 
morphological phenotypes across different tissues. Furthermore, mitochondria of cardiac cells in 
Mfn1 KO mice showed larger mitochondria whereas in Mfn2 KO cells, the mitochondria were 
fragmented implying that deletion of genes that have similar roles in mitochondrial morphology 
doesn’t necessarily lead to identical phenotypes and complicating the issue [31]. These 
observations suggest the need for a consistent and comprehensive method to assess mitochondr ia l 
morphology.  
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Developing Actin Based Tool for 
Mitochondrial Morphology Studies 
1. Background in Actin Polymerization 
Actin polymerization is one of the most universally employed mechanism to generate force in 
living cells such as endocytosis [34], cell migration [35], vesicle trafficking [36], and cytokines is 
[37]. There are various types of actin polymerization each initiated through a unique mechanism 
producing different forms of actin polymerization for different purposes. One is formin induced 
actin polymerization which creates unbranched actin filaments [38,40]. Another is spire proteins 
which initiates actin polymerization via WASP-homology 2 (WH2) domains [39,40]. Finally, 
there is Arp2/3 dependent actin polymerization which promotes actin polymerization by 
mimicking an actin dimer or trimer to provide a scaffold for successive actin filament binding [40].  
Arp2/3 dependent actin polymerization, in particular, requires the activity of nucleation promoting 
factors (NPFs). Some examples of NPFs are WASP, SCAR, and WAVE. Rho-family GTPases 
CDC42 and Rac activates the auto-inhibited NPFs which subsequently initiates actin 
polymerization by binding to Arp2/3 through its acidic domain [40]. The central region induces 
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conformational change of Arp2/3 and together with other domains delivers free actin polymers to 
the barbed ends of growing actin filaments and ATP hydrolysis reduces Arp2 interaction with 
mother filament preparing for additional branching or setting the onset of debranching.  
2. ActA from Listeria Monocytogenes   
Listeria Monocytogenes is a foodborne pathogen that causes listeriosis, a disease characterized by 
severe gastroenteritis, encephalitis, meningitis or septicemia, as well as miscarriage [41-45]. One 
of the fascinating features of Listeria is that it swims through the host cytoplasm by producing an 
actin comet tail. This is achieved through a protein called ActA which is asymmetrica l ly 
distributed along the surface of Listeria through its transmembrane domain [41-43]. This 
asymmetry along with having its various domains that trigger actin polymerization facing towards 
the host cytoplasm allows it to highjack the host actin machinery to form a self-propelling actin 
cloud. [44,45] That being said, ActA is sufficient to drive Listeria motility.  
So what is this protein called ActA? Through systematic domain analysis, it has been revealed that 
ActA is divided into domains that are similar to NPFs such as the proteins in the WASP family 
[41,46]. These domains include the signaling peptide, acidic domain, actin-monomer binding 
domain, cofilin-homology domain, proline-rich domain, and transmembrane domain. The acidic 
domain, actin-monomer binding domain, and cofiilin homology domain together constitute the 
minimal component required for actin polymerization and hence, Listeria motility [41,46]. It 
mimics the Verprolin-Cofilin-Acidic (VCA) domain of the WASP family. One key difference is 
that unlike the proteins of the WASP family, its activation is not dependent on Cdc42 and is in a 
constitutively active form. 
 The ability of ActA to bind to and activate Arp2/3 complex is achieved by the cofilin-homology 
domain and the efficiency and the rate of actin polymerization is accomplished through the acidic 
 9 
domain [42,43]. The proline rich domain contains four proline repeats which bind to Ena-VASP 
proteins by mimicking host cell cytoskeletal proteins such as zyxin, vinculin, and paladin [42]. 
Subsequent biochemical studies have shown that ActA has a higher affinity towards these Ena-
VASP proteins than the host cell cytoskeletal proteins [42,47]. Although these proteins are not 
required for Listeria motility, they increase the speed and directional persistence [47].  
3. ActA as a Tool? 
One of the first demonstration of ActA as force generator was shown in vitro bead studies where 
they’ve shown ActA alone is sufficient to stimulate Arp2/3 complex and initiate actin 
polymerization and generates actin comet tails [49-53]. Further examples of ActA as a molecular 
force generator include expressing ActA 
in S. Pneuoniae and coating synthet ic 
liposomes to provide actin-based 
motility.  
Some studies suggested that force 
generation is done through the addition 
of actin monomer between the space 
between the growing actin filaments and 
the membrane. The actin filament 
transiently binds and dissociates from the 
membrane and during this process actin 
monomers come into this gap pushing 
the membrane. The process is repeated 
Figure 2.1: Actin driven motility of ActA coated lipid 
vesicles. Vesicles were labeled with Oregon Green, and 
actin was labeled with rhodamine. (Adapted from Arpita 
Upadhyaya et al. PNAS, 2004) 
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until the actin filaments are capped and prevented from re-associating with the membrane. 
However, the overall biophysical mechanism by which each actin filaments cooperatively execute 
such dramatic behavior is yet to be resolved.  
 The large magnitude of force it generates is implicated in the high speed at which Listeria moves. 
It has been reported that in Xenopus frog egg cytoplasmic extracts, Listeria moves approximate ly 
100nm/s on average [49,50]. One group estimated the force generated by ActA using synthetic 
liposomes where they approximated the force to be around 3000pN/µm2 which was comparable 
to lamellipodia stall forces, 2000pN/µm2 [51]. That being said, it is imaginable to use ActA as a 
tool to deform membranes. Evaluation of ActA as a tool was conducted through the following five 
major experiments.  
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Experiment 1  
1.1 Codon Optimization and Characterization of 
Overexpressed ActA 
To date, expression of ActA in mammalian cells have not been reported; therefore, it is crucial to 
know how well this bacterial protein is expressed in mammalian cells and its effects on organelle 
morphology. We took the ActA gene and transferred it to a plasmid driven by mammalian 
expression promoter (CMV-promoter).  
Full length ActA was expressed in Hela cells; however, as shown in Fig 3.1, the expression was 
too low to carry out any meaningful experiment. We assumed this was due to the different codon 
usage between mammalian and bacterial cells, and therefore, we codon optimized ActA for 
mammalian expression (mActA) and as shown in Fig 3.1 (a), the expression improved.  
To assess the localization of mActA, we expressed mActA with either an endoplasmic reticulum 
(ER) marker (KDEL) or a mitochondria marker (Tom20) and a marker for F-actin (Lifeact). We 
found out that compared to the control cells, which did not have mActA expressed, the ER 
morphology was abnormally crowded around the periphery of the 
12
(a) 
(b)
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domain and signaling peptide region of mActA and named this truncated version as mActAdiff. We 
again coexpressed mActAdiff with an ER marker (KDEL), mitochondria marker (Tom20), and a F-
actin marker (Lifeact), and as expected, mActAdiff was now uniformly localized throughout the 
cell and the morphology of both mitochondria and ER looked normal as characterized by its highly 
networked and tubular structure. In addition, F-actin signal was high at the cytosol relative to the 
control. This was further confirmed with phalloidin staining.  
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Experiment 2 
2.1 mActAdiff to Perturb Organelle Morphology  
Based on what we’ve observed with the full length ActA, we hypothesized that accumulation of 
mActAdiff at a subcellular structure could mechanically deform the it through actin polymerizat ion. 
To test this idea, we took advantage of a method called chemically-inducible-dimerization (CID) 
in which two proteins FRB and FKBP dimerizes upon addition of a chemical called rapamycin 
[54].  
Either FRB or FKBP was fused to the C-terminus of mActAdiff and the other pair was fused to the 
outer membrane of the target organelle (Fig 3.2). We targeted mActAdiff to the outer membrane of 
the mitochondria, and seconds after translocating mActAdiff, the mitochondria tubules broke down 
into small circular like vesicles with high F-actin signal around the mitochondria as indicated by 
the Lifeact signal (Fig 3.3).   
15
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Experiment 3 
3.1 Characterizing the Mechanism of mActAdiff 
Induced Mitochondrial Fragmentation  
 
We further sought to determine whether the fragmentation was due to actin polymerization. To 
test this, we pretreated cells with Latrunculin A, which inhibits actin polymerization by 
sequestering free G-actin. After pretreating cells, mActAdiff was targeted to the outer membrane of 
the mitochondria. As shown in Fig 3.7, there was no visible mitochondrial fragmentation and no 
accumulation of F-actin at the mitochondria. Furthermore, we co-expressed Arp2, and after 
recruitment of mActAdiff, we saw an acute accumulation of Arp2 indicating that Arp2/3 was 
involved (Fig 3.6).  
20
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recovery of 0.233s. The mobile fraction was around 30% whereas for the control, it was around 
60%. This suggests that there is not much mitochondrial content flowing in and out of the 
fragmented mitochondria implying structural discontinuity.   
24
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Experiment 4 
4.1   Short Term Effects on the Mitochondrial 
Function 
Damaged mitochondria lose membrane potential, the ability to produce ATP, and affect ROS 
levels and calcium dynamics [55-58]. The malfunctioning mitochondria is recognized by the cell, 
and the impaired mitochondrial fragments undergo degradation through a process called 
mitophagy [55-58].  
To test whether artificially inducing mitochondrial fragmentation changes membrane potential, we 
translocated mActAdiff to the mitochondria and monitored the membrane potential using a dye 
called TMRE with its fluorescence as a readout. Few time points before the end of the imaging 
session, we added 10uM of CCCP as an internal positive control. Comparing the TMRE 
fluorescence values with the controls (DMSO: vehicle control, CCCP: positive control), we 
concluded there was nearly no change in membrane potential after fragmentation (Fig 3.12 (a)).  
28
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4.2   Long Term Effects on the Mitochondrial 
Function 
To see whether there were any long-term effects on the mitochondria, we looked for any 
indications of mitophagy. It has been reported that mitophagy goes through different stages 
recruiting different proteins along the way. Typically, an E4-ligase Parkin accumulates at the 
damaged mitochondria, and at a later stage, autophagy-specific adaptor protein LC3 starts to 
localize to the mitochondrial fragments which subsequently targets the mitochondria to 
autophagosomes [55-58] (Fig 3.14). Therefore, we used these two proteins as markers for 
mitophagy. An end-point assay was carried out where the mitochondria was fragmented with 
mActAdiff for 24hrs.  
In Hela cells, less than 5% of the total area of mitochondria colocalized with Parkin (Fig 3.15) and 
for LC3, it was also less than 5% (Fig 3.16). This was statistically insignificant compared with the 
vehicle control (P=0.9178 and 0.8037, respectively). This was further confirmed with the fact that 
the membrane potential did not change 24hrs post fragmentation (Fig 3.17). We then tested 
whether the results could be reproduced in a different cell line.  
In Cos7 cells, again less than 5% of the total area of mitochondria colocalized with Parkin and 
LC3 (Fig 3.15 and Fig 3.16). This was statistically insignificant compared with the vehicle control 
(P=0.9178 and 0.1932). Interestingly, the membrane potential decreased after 24hrs (Fig 3.17).   
Furthermore, in H9C2 cells, less than 5% of the total area of the mitochondria colocalized with 
Parkin and LC3. This was statistically insignificant compared with the vehicle control (P= 0.8442 
and 0.0697). However, the membrane potential increased for H9C2 cells (Fig 3.17). For follow up 
experiments, it would be interesting if this translates to increase in ATP production rate.   
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Figure 3.15:  Long term effects of mActAdiff and Parkin co-localization. Hela, Cos7, and H9C2 cells were 
subjected to fragmentation with either mActAdiff or 10uM of CCCP for 24hrs. Data presents percentage area of 
mitochondria that colocalized with Parkin puncta. For Hela cells, P= 0.808 and 0.343x10-4. For Cos7 cells, 
P=0.9178 and 0.246x10-10. For H9C2 cells, P= 0.8442 and 0.001. (N.S indicates no statistical difference between 
the two groups. *P<0.1 **P<0.05, ***P<0.001.) 3 independent experiments were conducted. 
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Figure 3.16:  Long term effects of mActAdiff and LC3 co-localization. Hela, Cos7, and H9C2 cells were subjected 
to fragmentation with either mActAdiff or 10uM of CCCP for 24hrs. Data presents percentage area of mitochondr ia 
that colocalized with LC3 puncta. For Hela cells, P= 0.8037 and 0.0291. For Cos7 cells, P=0.1932 and 0.9936. For 
H9C2 cells, P= 0.1933 and 0.0697. (N.S indicates no statistical difference between the two groups. *P<0.1 
**P<0.05, ***P<0.001.) 3 independent experiments were conducted. 
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Figure 3.17:  Long term effects on mitochondrial membrane potential. Hela, Cos7, and H9C2 cells were 
subjected to fragmentation with either mActAdiff or 10uM of CCCP for 24hrs. Data presents percentage area of 
mitochondria that colocalized with Parkin puncta. For Hela cells, P= 0.6124 and 0.608x10-4. For Cos7 cells, 
P=0.0014 and 0.06. For H9C2 cells, P= 0.0142 and 0.4772x10-15. (N.S indicates no statistical difference between 
the two groups. *P<0.1 **P<0.05, ***P<0.001.) 3 independent experiments were conducted. 
35
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completely from the surface of the mitochondria and hence, persistently applying force. To tackle 
this issue, we resorted to light- inducible dimerization. Amongst the many light- induc ib le 
dimerization systems, we selected the light- induced dimer (iLID) system. iLID is composed of 
light-oxygen-voltage 2 (LOV2) domain from Avena sativa and a bacterial SsrA peptide. In the 
dark, SsrA is sterically inhibited and cannot bind to its partner, SspB. Upon illumination of blue 
light, LOV2 opens up allowing SsrA to bind to SspB [59]. Hoping to reversibly control force 
generation (Fig 3.18), we fused mActAdiff to SspB and fused the mitochondrial outer membrane 
anchor protein, either MOA or TOM20, to iLID. After shining with 488nm laser, we saw an 
accumulation of mActAdiff at the mitochondria which subsequently lead to mitochondr ia l 
fragmentation. As soon as we shut off the light, we saw mActAdiff dissociate and the shape of the 
mitochondria returned to its initial tubular shape. We repetitively turned on and off the light and 
observed the mitochondria go from fragmentation to tubular forms (Fig 3.19 (a)). This was also 
reflected in F-actin signal increasing and decreasing at the surface of the mitochondria (Fig 3.19 
(b), (c)) demonstrating that it is possible to control mitochondrial morphology. 
37
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Conclusion 
Deciphering the role of organelle morphology and its relevance to diseases has long been 
researcher’s interest; however, limitation in existing tools to dissociate morphology and function 
has restricted our understanding of its true significance. In this study, we introduced a genetica lly 
encoded tool, mActAdiff, that could be used to directly change mitochondrial morphology, and 
potentially applied to other organelles as well.  
We’ve shown that the fragmentation was actin dependent by inhibiting actin polymerization with 
Latrunculin A, involved Arp2/3 complex and was also independent of myosin II and Drp1. 
Furthermore, according to FRAP, each of mitochondrial fragments were discontinuous from each 
other. The fragmentation process could be similar to the process observed by Higgs’s Group where 
they have shown that ER mediated actin polymerization recruits Drp1to constriction sites [60]. We 
don’t know whether the differences we see in fragmentation across various cell lines is due to the 
variation in the physical property of the mitochondria or the disparities in expression level of 
mitochondrial fusion/fission proteins. Regardless, for all cases, we observed mitochondr ia l 
filament- like structures budding from the body of the mitochondria lead by an actin and ActA rich 
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head, subsequently leading to mitochondrial fragmentation. This could be a result of mActAdif f  
pushing and creating a slight dent in the mitochondria redirects the force. In future experiments, it 
is important to elucidate whether mActAdiff is fragmenting the mitochondria by pure force or 
through the help of endogenous fission machinery. It will be also interesting to see whether the 
inner membrane space or cristae capacity changes upon fragmentation. 
We have shown that mActAdiff induced mitochondrial fragmentation did not lead to any changes 
in membrane potential and ATP levels. Furthermore, there was no conclusive evidence of Parkin 
mediated mitophagy. Such results may suggest that the mitochondria were not damaged, but 
recalling how compelling the fragmentation was, it is hard to dismiss the possibility that there is 
perturbation. Another degradation process could be activated that is independent of Parkin. Further 
characterization is required such as evaluating the dynamic activity of the mitochondria or overall 
status of the cell. Do the mitochondria start to rely on a specific step of the electron transport chain? 
Are there any changes in import and export rate of certain molecules? Does the cell become more 
susceptible to drugs that otherwise would not be? These are some examples that could be perturbed 
by our system that is not captured in our assays. 
Nevertheless, we have shown how effective our tool is to cause fragmentation. With the help of 
optogenetics, we believe this new tool will provide a new paradigm in studying organelle 
morphology, in particular mitochondrial morphology, by overcoming the limitations in the 
aforementioned methods to study mitochondrial moprhology.   
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Materials/Methods 
Cell Culture and Transfection 
All DNA constructs were transiently transfected using FugeneHD as a transfection reagent. Cells 
were plated on poly-D-lysine hydrobromide (Sigma)-coated cover glass. Cells were cultured in 
Dulbecco’s modified Eagle’s medium (DMEM;Gibco) supplemented with 10% fetal bovine serum 
and 1% penicillin/streptomycin at 37°C in 5% CO2.  
Image Acquisition and Processing 
24hr after transfection, cells were washed with Dublecco’s Phosphate-Buffered Saline (DPBS) and 
fluorescent images of cells were taken using a.  63× objective (Plan‐Apochromat, NA=1.4, Zeiss) 
mounted on an inverted Axiovert 135 TV microscope (Zeiss) and were captured by a QIClick 
charge‐coupled device camera (QImaging). FRAP and light- induced dimerization experiments 
were conducted under Zeiss LSM780.  Captured images were analyzed using an image processing 
software, Metamorph. All scale bars are 10um. 
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Membrane Potential Analysis 
Hela and H9C2 cells were stained with TMRE at a final concentration of 7nM whereas Cos7 cells 
were stained at a final concentration of 35nM. 10uM of CCCP was used to impair the membrane 
potential of the mitochondria or to induce mitophagy. 3 to 4 independent experiments were 
conducted. 
ATP Level Analysis 
To measure the ATP levels in the mitochondrial matrix, an ATP FRET sensor, ATeam Series [61], 
was used. To lower the ATP levels, cells were cultured in either phenol red free DMEM with 
25mM HEPES or the pyruvate free counterpart. 2-Deoxy-D-glucose (2-DG) was applied at a final 
concentration of 25mM to the cells to induce decrease in ATP level. 3 to 4 independent 
experiments were conducted.  
Actin and Myosin II Inhibition 
Actin polymerization was inhibited with Latrunculin A at a final concentration 500nM. Myosin II 
was inhibited using blebbistatin at a final concentration of 50uM.  
Chemically-Induced-Dimerization and Light-Induced-
Dimerization 
Chemically-Induced-Dimerization was performed by adding rapamycin at a final concentration of 
100nM to the prepared samples at the desired time point. Light-Induced-Dimerization was 
performed with Zeiss LSA780. Regions that were to be stimulated were selected using the built-
in software and stimulated with the 488nm laser.  
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Data Analysis 
Either two-tailed student’s t-test or one-way ANOVA following post hoc Scheffe’s Method was 
used. All error bars are standard deviations. 
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